Opinion
No. 11–1078.
2013-01-14
GLAXOSMITHKLINE, petitioner, v. CLASSEN IMMUNOTHERAPIES, INC.
Case below, 659 F.3d 1057.
Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
From Casetext: Smarter Legal Research
Glaxosmithkline v. Classen Immunotherapies, Inc.
Supreme Court of the United States
Jan 14, 2013
568 U.S. 1137 (2013)
Summaries of
Glaxosmithkline v. Classen Immunotherapies, Inc.
Supreme Court of the United States
Jan 14, 2013
568 U.S. 1137 (2013)
denying cert.
Summary of this case from Classen Immunotherapies, Inc. v. Biogen IdecCase details for
Glaxosmithkline v. Classen Immunotherapies, Inc.
Case Details
Full title:GLAXOSMITHKLINE, petitioner, v. CLASSEN IMMUNOTHERAPIES, INC.
Court:Supreme Court of the United States
Date published: Jan 14, 2013
Citations
568 U.S. 1137 (2013)
133 S. Ct. 973
184 L. Ed. 2d 751
81 U.S.L.W. 3386
Citing Cases
Classen Immunotherapies, Inc. v. Biogen Idec
On August 31, 2011, the Federal Circuit held that the '139 and '739 patents are eligible for patent…
Classen Immunotherapies, Inc. v. IdecClassen appealed, and on August 31, 2011, the Federal Circuit reversed, holding that the '139 and '739…